Medicine and Dentistry
Non Small Cell Lung Cancer
74%
Mesothelioma
71%
Cells
51%
Growth
49%
Initiation Factor 4E
45%
Chemosensitivity
44%
Initiation Factor 4F
43%
Therapeutic Procedure
36%
Cancer Cell
35%
Cancer
35%
Defence Mechanisms
32%
Protein
31%
Antisense Oligonucleotide
30%
Combination Therapy
26%
In Vitro
19%
Programmed Cell Death
18%
Stimulation
18%
Phenotype
17%
Lung Cancer
16%
Xenograft
16%
Signal Transduction
15%
Gemcitabine
15%
Neoplasm
14%
Prodrug
14%
Mesenchymal Stem Cell
14%
Gene
14%
Tritium
14%
Erlotinib
14%
Simocyclinone D8
14%
Epidermal Growth Factor Receptor
14%
Sarcoplasmic reticulum
14%
Regulatory Mechanism
14%
Measles Virus
14%
Epidermal Growth Factor Receptor Kinase Inhibitor
14%
Esophageal Adenocarcinoma
14%
Virus Infection
14%
Malignant Hyperthermia
14%
Somatomedin C Receptor
14%
Tryptamine
14%
Chemosensitization
14%
Triptolide
14%
Gene Expression
14%
Ryanodine
14%
Chemotherapy
13%
Phosphorylation
12%
Pemetrexed
12%
Cell Proliferation
11%
Messenger RNA
10%
Guanosine Phosphate
10%
Treatment of Non-Small Cell Lung Cancer
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
72%
Protein
63%
Nested Gene
50%
Chemosensitivity
42%
Growth
36%
Translation Initiation
31%
Defense Mechanism
30%
Eukaryotic Initiation Factor
29%
Escherichia
28%
Escherichia coli
28%
Phenotype
25%
Regulatory Mechanism
25%
Electric Potential
22%
Operon
21%
Mutant
20%
Wild Type
19%
Inverted Repeat
19%
Pemetrexed
17%
Signal Transduction
17%
Cell Proliferation
16%
Promoter Region
16%
Translation (Protein Synthesis)
16%
N-Terminus
16%
Oligonucleotide
15%
Kinase
15%
Initiation Factor
15%
Eukaryotic Translation
15%
Small Molecule
15%
Antisense
15%
Messenger RNA
15%
Inversion
14%
Insulin-Like Growth Factor
14%
Hybrid
14%
Chromosome 20
14%
AT Rich Sequence
14%
Thioredoxin
14%
Guanosine Monophosphate
14%
Chemosensitization
14%
Tryptamine
14%
CD44
14%
Gene Expression
14%
Cell Cycle Regulation
14%
Antiproliferative Activity
14%
Epidermal Growth Factor Receptor
14%
Halothane
14%
Interferon
14%
Erlotinib
14%
Ruxolitinib
14%
Topoisomerase
14%
Anabaena
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Mesothelioma
73%
Interferon
42%
Vesiculovirus
41%
Apoptosis
38%
Initiation Factor 4F
36%
Malignant Neoplasm
31%
Virotherapy
29%
Aminoacridine Derivative
28%
Acridine
28%
Western Blot
25%
Initiation Factor 4E
25%
Cell Proliferation
23%
DNA Topoisomerase (ATP Hydrolysing)
22%
Neoplasm
19%
Vaccine Strain
19%
Virus Infection
18%
DNA
18%
Clinical Trial
17%
Lung Cancer
17%
Small Cell Lung Cancer
16%
Antisense Oligonucleotide
15%
Poisons
15%
Ruxolitinib
15%
Protein
14%
Prodrug
14%
Triptolide
14%
Measles Virus
14%
Oligonucleotide Targeting
14%
Cancer Model
14%
Somatomedin C Receptor
14%
Tryptamine
14%
Erlotinib
14%
Gyrase Inhibitor
14%
Epidermal Growth Factor Receptor Kinase Inhibitor
14%
Escherichia
14%
Cell Death
13%
Gemcitabine
12%
Mouse
12%
Antagonist
8%
Cell Cycle
8%
DNA Topoisomerase
7%
Binding Site
7%
Survival
7%
Prognosis
6%
Combination Therapy
6%
Survivin
6%
Acridine Derivative
5%
Death
5%
Etoposide
5%